Biomendex

Adaptos® — a bioactive synthetic bone graft substitute the surgeon can cut, shape or squeeze into place, which rigid conventional grafts do not allow. Clinical and veterinary use; collaboration with Mayo Clinic announced 10/2024.

The row

Sector

Medtech & Digital Health

Stage

In market — Product is being sold

Location

Tampere

Founded

2018

Research origin

Tampere Univ.

Business ID

2946392-2 · Finnish trade register

Funding

~€1M round (private investors, Business Finland, Horizon 2020) + EU grant of up to €2.2M over 24 months + Business Finland Deep Tech Accelerator (2023)

Links

Where this sits on the map

Biomendex is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗